Newsfeeds Archive - Page 594 of 608

3 minute read

Why Walmart is Trading Higher By More Than 9%: Here Are 25 Stocks Moving Premarket

July 26, 6:42 AM

Gainers Ayala Pharmaceuticals, Inc. (NASDAQ: AYLA) rose 64.4% to $1.43 in pre-market trading. Ayala Pharmaceuticals filed request for withdrawal of registration statement on form S-1.

AAN

2 minute read

U.S. Stock Futures Down Ahead Of Big Earnings, Fed Meeting

By Lisa Levin

July 26, 5:54 AM

Pre-open movers

AAN

4 minute read

Why Energy Stocks Traded Higher; Here Are 61 Biggest Movers From Yesterday

By Lisa Levin

July 26, 5:32 AM

Gainers GeoVax Labs, Inc. (NASDAQ: GOVX) jumped 150.4% to close at $1.59 on Monday after declining 8% on Friday.

ABOS

1 minute read

Alphabet, Microsoft And 5 Stocks To Watch Heading Into Tuesday

By Lisa Levin

July 26, 4:46 AM

With US stock futures trading lower this morning on Tuesday ahead of earnings reports from several big companies, some of the stocks that may grab investor focus today are as follows:

1 minute read

Bitcoin Drops Further To This Level, Here Are Other Crypto Movers That Should Be On Your Radar

By Lisa Levin

July 26, 4:25 AM

Bitcoin (CRYPTO: BTC), the world’s oldest cryptocurrency, declined to the $21,000 mark, recording sharp losses on Tuesday.

$BUSD

1 minute read

All Eyes On Fed Meeting, Here Are The Major Macro Issues For Tuesday

By Lisa Levin

July 26, 3:58 AM

The Dow Jones gained by around 90 points on Monday, after RPM International Inc. (NYSE: RPM) reported mixed Q2 results.

RPM

1 minute read

Zymergen, World Wrestling Entertainment And Some Other Big Stocks Moving Higher On Monday

By Lisa Levin

July 25, 12:51 PM

CVI

2 minute read

Dow Rises Over 100 Points; Revelation Biosciences Shares Spike Higher

By Lisa Levin

July 25, 12:43 PM

U.S. stocks traded mostly higher midway through trading on Monday.

BORR

3 minute read

Why Is Infrastructure and Energy Alternatives Higher By Around 29%? 37 Stocks Moving In Monday’s Mid-Day Session

By Lisa Levin

July 25, 12:36 PM

Gainers Revelation Biosciences, Inc. (NASDAQ: REVB) jumped 104% to $1.3263 after the company announced that primary endpoint was met in study for its treatment of allergic rhinitis.

ADXN